Skye Bioscience, Inc.
SKYE
$2.23
$0.3518.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -79.29% | -71.11% | -62.38% | -47.62% | -34.45% |
| Total Receivables | -45.19% | -34.93% | 105.88% | 32.28% | -97.54% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -67.15% | 112.63% | 149.95% | 458.58% | 15.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -34.41% | -92.99% | -61.82% | -92.46% | -93.59% |
| Total Current Assets | -78.33% | -70.54% | -61.75% | -49.97% | -41.86% |
|
|
|||||
| Total Current Assets | -78.33% | -70.54% | -61.75% | -49.97% | -41.86% |
| Net Property, Plant & Equipment | -95.63% | -52.45% | -38.09% | -20.90% | 512.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -84.60% | -33.40% | 0.00% | 104.94% | 549.40% |
| Total Assets | -78.85% | -70.03% | -61.09% | -49.32% | -40.22% |
|
|
|||||
| Total Accounts Payable | 32.77% | 129.72% | 257.18% | 262.18% | 198.52% |
| Total Accrued Expenses | -46.35% | 138.16% | 121.28% | 10.71% | 37.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -81.69% | -67.66% | 3.95% | 143.18% | 146.21% |
| Total Finance Division Other Current Liabilities | 199.94% | 34.59% | 13.76% | 14.62% | -70.16% |
| Total Other Current Liabilities | 199.94% | 34.59% | 13.76% | 14.62% | -70.16% |
| Total Current Liabilities | 38.73% | 95.60% | 89.11% | 48.78% | -41.97% |
|
|
|||||
| Total Current Liabilities | 38.73% | 95.60% | 89.11% | 48.78% | -41.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -69.25% | 11.19% | 32.79% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 35.91% | 87.72% | 79.74% | 48.07% | -41.30% |
|
|
|||||
| Common Stock & APIC | 3.11% | 3.52% | 3.92% | 4.19% | 6.96% |
| Retained Earnings | -31.62% | -40.36% | -42.71% | -42.27% | -36.12% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -101.14% | -84.79% | -70.62% | -56.68% | -40.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -101.14% | -84.79% | -70.62% | -56.68% | -40.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -101.14% | -84.79% | -70.62% | -56.68% | -40.01% |
|
|
|||||